Galit Alter, PhD, Group Leader at the Ragon Institute of MGH, MIT and Harvard and Professor of Medicine at Harvard Medical School, and Helen Chu, MD, Associate Professor of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, and UW Medicine physician, have recently published a paper which identifies five immune response markers which, collectively, were able to correctly classify both convalescent COVID-19 patients and those who did not survive the disease. The study was published in the journal Immunity.

For our comprehensive coverage and latest updates on COVID-19 click here.

Dr. Chu's team, responsible for the enrollment, collection, and management of the clinical work in this study, collected samples hospitalized COVID-19 patients. Overall, this study used samples from a cohort of 22 individuals, 12 of whom recovered, and 10 of whom died.

Dr. Alter's team used her systems serology technique, an approach that relies on 60+ assays to create a detailed profile of the immune response, to compare the immune responses of those who had survived to those who had not.